CLINICAL_TRIALS
trial_result
· 2020-05-22
Clinical Trial Update: Baricitinib for coRona Virus pnEumonia (COVID-19): a THerapeutic Trial [Phase 2]
Summary
A Phase 2 clinical trial update for baricitinib in COVID-19 pneumonia is listed with unknown status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Corona Virus Infection | Phase 2 | Status: UNKNOWN